Showing results (151-160 of 174) with videos related to

Sort By:
Pageof 18
Molecular Psychiatry|January 4, 2006
Association analysis of the chromosome 4p-located G protein-coupled receptor 78 (GPR78) gene in bipolar affective disorder and schizophreniaS L Underwood, A Christoforou, P A Thomson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2008
A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorderB S Pickard, H M Knight, R S Hamilton, et al.
Translational Psychiatry|April 19, 2017
Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association dataJ Gibson, T C Russ, M J Adams, et al.
Translational Psychiatry|September 24, 2014
Are APOE ɛ genotype and TOMM40 poly-T repeat length associations with cognitive ageing mediated by brain white matter tract integrity?D M Lyall, S E Harris, M E Bastin, et al.
Translational Psychiatry|November 2, 2016
Dissection of major depressive disorder using polygenic risk scores for schizophrenia in two independent cohortsH C Whalley, M J Adams, L S Hall, et al.
Gene Therapy|March 1, 1997
Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisD J Porteous, J R Dorin, G McLachlan, et al.
Genomics|February 15, 2001
A 6.9-Mb high-resolution BAC/PAC contig of human 4p15.3-p16.1, a candidate region for bipolar affective disorderK L Evans, S Le Hellard, S W Morris, et al.
Gene Therapy|December 1, 1996
Laboratory and clinical studies in support of cystic fibrosis gene therapy using pCMV-CFTR-DOTAPG McLachlan, L P Ho, H Davidson-Smith, et al.
Molecular Psychiatry|June 21, 2017
Rare disruptive variants in the DISC1 Interactome and Regulome: association with cognitive ability and schizophreniaS Teng, P A Thomson, S McCarthy, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 21, 2000
No association between the alpha2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expressionK Blennow, A Ricksten, J A Prince, et al.
Pageof 18